The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Prevalence of renal insufficiency (RI) in cancer (Ca) patients (pts) with bone metastases (BM).
Kristina S Chen
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
Rohini Khorana Hernandez
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
Jane M Quigley
Consultant or Advisory Role - IMS Health
Melissa A. Pirolli
Consultant or Advisory Role - IMS Health
David Quach
Consultant or Advisory Role - IMS Health
Alexander Liede
Employment or Leadership Position - Amgen
Stock Ownership - Amgen
Jorge Arellano
Employment or Leadership Position - Amgen
Stock Ownership - Amgen